Search research articles
Contact Us
Filters
Showing results (41-50 of 152) with videos related to
Page
of 16
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
November 16, 2023
Predicting the pharmacokinetics and pharmacodynamics of antisense oligonucleotides: an overview of various approaches and opportunities for PBPK/PD modelling
Xiang Gao, John K Diep, Daniel A Norris, et al.
Oligonucleotides
|
December 2, 2010
In vitro metabolic stabilities and metabolism of 2'-O-(methoxyethyl) partially modified phosphorothioate antisense oligonucleotides in preincubated rat or human whole liver homogenates
Min-Son Baek, Rosie Z Yu, Hans Gaus, et al.
Nucleic Acid Therapeutics
|
April 23, 2021
Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of GalNAc3-Conjugated and Unconjugated-Antisense Oligonucleotides
Charvi Nanavati, Gina McMullen, Rosie Yu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 24, 2002
Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs
Araz A Raoof, Zeibun Ramtoola, Brain McKenna, et al.
Anti-Cancer Drug Design
|
July 1, 1997
Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides
R S Geary, J M Leeds, S P Henry, et al.
Biochemical Pharmacology
|
April 28, 2009
Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2'-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN
Richard S Geary, Ed Wancewicz, John Matson, et al.
Microscopy Research and Technique
|
May 1, 1995
SEM comparison of Morpho butterfly dorsal and ventral scales
L Bingham, I Bingham, S Geary, et al.
Archives of Environmental Health
|
April 16, 1998
Maternal residential exposure to hazardous wastes and risk of central nervous system and musculoskeletal birth defects
E G Marshall, L J Gensburg, D A Deres, et al.
Biochemical Pharmacology
|
August 18, 2020
Antisense drug discovery and development technology considered in a pharmacological context
Stanley T Crooke, Xue-Hai Liang, Rosanne M Crooke, et al.
Journal of Robotic Surgery
|
February 16, 2021
Uptake and outcomes of robotic gynaecological surgery in England (2006-2018): an account of Hospital Episodes Statistics (HES)
D El-Hamamsy, R S Geary, I Gurol-Urganci, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 152) with videos related to
Sort By:
Page
of 16
Expert Opinion on Drug Metabolism & Toxicology
|
November 16, 2023
Predicting the pharmacokinetics and pharmacodynamics of antisense oligonucleotides: an overview of various approaches and opportunities for PBPK/PD modelling
Xiang Gao, John K Diep, Daniel A Norris, et al.
Oligonucleotides
|
December 2, 2010
In vitro metabolic stabilities and metabolism of 2'-O-(methoxyethyl) partially modified phosphorothioate antisense oligonucleotides in preincubated rat or human whole liver homogenates
Min-Son Baek, Rosie Z Yu, Hans Gaus, et al.
Nucleic Acid Therapeutics
|
April 23, 2021
Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of GalNAc3-Conjugated and Unconjugated-Antisense Oligonucleotides
Charvi Nanavati, Gina McMullen, Rosie Yu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 24, 2002
Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs
Araz A Raoof, Zeibun Ramtoola, Brain McKenna, et al.
Anti-Cancer Drug Design
|
July 1, 1997
Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides
R S Geary, J M Leeds, S P Henry, et al.
Biochemical Pharmacology
|
April 28, 2009
Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2'-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN
Richard S Geary, Ed Wancewicz, John Matson, et al.
Microscopy Research and Technique
|
May 1, 1995
SEM comparison of Morpho butterfly dorsal and ventral scales
L Bingham, I Bingham, S Geary, et al.
Archives of Environmental Health
|
April 16, 1998
Maternal residential exposure to hazardous wastes and risk of central nervous system and musculoskeletal birth defects
E G Marshall, L J Gensburg, D A Deres, et al.
Biochemical Pharmacology
|
August 18, 2020
Antisense drug discovery and development technology considered in a pharmacological context
Stanley T Crooke, Xue-Hai Liang, Rosanne M Crooke, et al.
Journal of Robotic Surgery
|
February 16, 2021
Uptake and outcomes of robotic gynaecological surgery in England (2006-2018): an account of Hospital Episodes Statistics (HES)
D El-Hamamsy, R S Geary, I Gurol-Urganci, et al.
Page
of 16